Molecular Epidemiology of HIV in Ghana: Dominance of CRF02_AG

Journal of Medical Virology

Volumn 73, Issue 2, 2004, Pages 158-166

  Fischetti, Lucia ^a   Opare Sem, Ohene ^b   Candotti, Daniel ^c   Sarkodie, Francis ^b   Lee, Helen ^a   Allain, Jean Pierre ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d East Anglia Blood Centre   (United Kingdom)

Author keywords

CRF02_AG; Epidemiology; Ghana; HIV

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CLINICAL FEATURE; ENVELOPE GENE; EPIDEMIOLOGICAL DATA; FEMALE; GENE CLUSTER; GENETIC VARIABILITY; GHANA; GROUP SPECIFIC ANTIGEN GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS CRF02 AG; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRAIN IDENTIFICATION; STRUCTURAL GENE; SYMPTOMATOLOGY; UNINDEXED SEQUENCE; VIRUS RECOMBINANT; VIRUS TYPING;

ADULT; CLUSTER ANALYSIS; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENES, ENV; GENES, GAG; GENES, POL; GENES, VIRAL; GENOTYPE; GHANA; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 2142757237     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20070     Document Type: Article

References (43)

1. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, Shyamala V, Yeboah F, Anokwa M, Owusu-Ofori S, Opare-Sem O. 2003. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101:2419-2425.
2. Ampofo WK, Koyanagi Y, Brandful J, Ishikawa K, Yamamoto N. 1999. Seroreactivity clarification and viral load quantitation in HIV-1 and HIV-2 infections in Ghana. J Med Dent Sci 46:53-62.
3. Andersson S, Norrgren H, Dias F, Biberfeld G, Albert J. 1999. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 262:312-320.
4. Arya SK, Gallo RC. 1996. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: A new approach to gene therapy of HIV-infection. Proc Natl Acad Sci USA 93:4486-4491.
5. Brandful JA, Ampofo WK, Janssens W, Adu-Sarkodie Y, Apeagyei F, Anyomi F, Aidoo S, Yamamoto N, Ishikawa K, Sata T, Kurata T. 1998. Genetic and phylogenetic analysis of HIV type 1 strains from southern Ghana. AIDS Res Hum Retroviruses 14: 815-819.
6. Candotti D, Sarkodie F, Allain JP. 2001. Residual risk of transfusion in Ghana. Br J Haematol 113:37-39.
7. Carr JK, Salminen MO, Albert J, Sanders-Buell E, Gotte D, Birx DL, McCutchan FE. 1998. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 247:22-31.
8. Carr JK, Laukkanen T, Salminen MO, Albert J, Alaeus A, Kim B, Sanders-Buell E, Birx DL, McCutchan FE. 1999. Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS 13:1819-1826.
9. Chang LW, Osei-Kwasi M, Boakye D, Aidoo S, Hagy A, Curran JW, Vermund SH. 2002. HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa. J Acquir Immune Defic Syndr 29:511-516.
10. Cornelissen M, van den Burg R, Zorgdrager F, Lukashov V, Goudsmit J. 1997. Pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. J Virol 71:6348-6358.
11. Cornelissen M, van Den Burg R, Zorgdrager F, Goudsmit J. 2000. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J Gen Virol 81:515-523.
12. Davies FJ, d'Almeida O, Timmers E, d'Ameida J, Fasken M, Bassabi K, Lee H, Allain JP. 1999. Molecular genotyping of HIV-1 in 61 patients with AIDS from Lome, Togo. J Med Virol 57:25-30.
13. Esteves A, Parreira R, Piedade J, Venenno T, Canas-Ferreira WF. 2000. Genetic characterization of HIV type 1 and type 2 from Bissau, Guinea-Bissau (West Africa). Virus Res 68:51-61.
14. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, Coppens S, Vereecken K, De Witte K, Van Rampelbergh R, Kahindo M, Morison L, McCutchan FE, Carr JK, Albert J, Essex M, Goudsmit J, Asjo B, Salminen M, Buve A, van Der Groen G. 2000. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study group on heterogeneity of HIV epidemics in African cities. J Virol 74:363-370.
15. Holguin A, Alvarez A, Soriano V. 2002. High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. AIDS 16:1163-1170.
16. Howard TM, Rasheed S. 1996. Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. AIDS Res Hum Retroviruses 12:1413-1425.
17. Ishikawa K, Janssens W, Brandful J, Heyndrickx L, Takebe Y, Ampofo W, Sata T, Yamazaki S, Osei-Kwasi M, Yamamoto N, Koyanagi Y, Van der Groen G, Kurata T. 1996. Genetic and phylogenetic analysis of HIV type 1 env subtypes in Ghana, West Africa. AIDS Res Hum Retroviruses 12:1575-1578.
18. Ishikawa K, Fransen K, Ariyoshi K, Nkengasong JN, Janssens W, Heyndrickx L, Whittle H, Diallo MO, Ghys PD, Coulibaly IM, Greenberg AE, Piedade J, Canas-Ferreira W, van der Groen G. 1998. Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS 12:1419-1425.
19. Ishikawa K, Janssens W, Banor JS, Shinno T, Piedade J, Sata T, Ampofo WK, Brandful JA, Koyanagi Y, Yamamoto N, Canas-Ferreira WF, Adu-Sarkodie Y, Kurata T. 2001. Genetic analysis of HIV type 2 from Ghana and Guinea-Bissau, West Africa. AIDS Res Hum Retroviruses 17:1661-1663.
20. Janssens W, Salminen MO, Laukkanen T, Heyndrickx L, van der Auwera G, Colebunders R, McCutchan FE, van der Groen G. 2000. Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. AIDS Res Hum Retroviruses 16:1183-1189.
21. Kokkotou EG, Sankale JL, Mani I, Gueye-Ndiaye A, Schwartz D, Essex ME, Mboup S, Kanki PJ. 2000. In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci USA 97:6797-6802.
22. Mamadou S, Montavon C, Ben A, Djibo A, Rabiou S, Mboup S, Delaporte E, Peeters M. 2002. Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa. AIDS Res Hum Retroviruses 18:723-726.
23. Mamadou S, Vidal N, Montavon C, Ben A, Djibo A, Rabiou S, Soga G, Delaporte E, Mboup S, Peeters M. 2003. Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa. AIDS Res Hum Retroviruses 19:77-82.
24. McCutchan FE, Carr JK, Bajani M, Sanders-Buell E, Harry TO, Stoeckli TC, Robbins KE, Gashau W, Nasidi A, Janssens W, Kalish ML. 1999. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 254:226-234.
25. Montavon C, Bibollet-Ruche F, Robertson D, Koumare B, Mulanga C, Esu-Williams E, Toure C, Mboup S, Saman E, Delaporte E, Peeters M. 1999. The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. AIDS Res Hum Retroviruses 15:1707-1712.
26. Montavon C, Toure-Kane C, Liegeois F, Mpoudi E, Bourgeois A, Vergne L, Perret JL, Boumah A, Saman E, Mboup S, Delaporte E, Peeters M. 2000. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 23: 363-374.
27. Montavon C, Toure-Kane C, Nkengasong JN, Vergne L, Hertogs K, Mboup S, Delaporte E, Peeters M. 2002. CRF06-cpx: A new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquir Immune Defic Syndr 29:522-530.
28. Nyambi P, Heyndrickx L, Vereecken K, Burda S, De Houwer K, Coppens S, Urbanski M, Williams C, Ndumbe P, Janssens W. 2002. Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS 16:295-296.
29. Oelrichs RB, Workman C, Laukkanen T, McCutchan FE, Deacon NJ. 1998. A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. AIDS Res Hum Retroviruses 14:1495-1500.
30. Ortiz M, Munoz L, Bernal A, Rodriguez A, Zorraquino A, Vadillo J, Salas A, Moreno A, Garcia-Saiz A. 2000. Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain. AIDS Res Hum Retroviruses 16(18):1967-1971.
31. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J, WHO-UNAIDS Network for HIV Isolation and Characterization. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 29:184-190.
32. Peeters M, Koumare B, Mulanga C, Brengues C, Mounirou B, Bougoudogo F, Ravel S, Bibollet-Ruche F, Delaporte E. 1998. Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali. AIDS Res Hum Retroviruses 14:51-58.
33. Peeters M, Esu-Williams E, Vergne L, Montavon C, Mulanga-Kabeya C, Harry T, Ibironke A, Lesage D, Patrel D, Delaporte E. 2000. Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution. AIDS Res Hum Retroviruses 16:315-325.
34. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Kalish ML, Salminen M, Sharp PM, Wolinsky S, Korber B. 1999. HIV-1 nomenclature proposal. In: Kuiken CL, Foley B, Hahn B, Korber B, McCutchan F, Marx PA, Mellors JW, Mullins JI, Sodroski J, Wolinksy S, editors. Human retroviruses and AIDS 1999: A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory.
35. Sagoe KW, Britton S, Mingle JA, Affram K, Djokoto A, Sonnerborg A. 1999. Similar HIV-1 subtype AV3 loop sequences are found in dual HIV-1/HIV-2 and HIV-1-only seropositives in Ghana. AIDS Res Hum Retroviruses 15:775-779.
36. Sarkodie F, Adarkwa M, Adu-Sarkodie Y, Candotti D, Acheampong JW, Allain JP. 2001. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang 80:142-147.
37. Sarr AD, Sankale JL, Gueye-Ndiaye A, Essex M, Mboup S, Kanki PJ. 2000. Genetic analysis of HIV type 2 in monotypic and dual HIV infections. AIDS Res Hum Retroviruses 16:295-298.
38. Sawadogo S, Adje-Toure C, Bile CE, Ekpini RE, Chorba T, Nkengasong JN. 2003. Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Cote d'Ivoire. J Clin Microbiol 41:3056-3059.
39. Takehisa J, Osei-Kwasi M, Ayisi NK, Hishida O, Miura T, Igarashi T, Brandful J, Ampofo W, Netty VB, Mensah M, Yamashita M, Ido E, Hayami M. 1997. Phylogenetic analysis of HIV type 2 in Ghana and intrasubtype recombination in HIV type 2. AIDS Res Hum Retroviruses 13:621-623.
40. Tebit DM, Zekeng L, Kaptue L, Salminen M, Krausslich HG, Herchenroder O. 2002. Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses 18:39-48.
41. Toure-Kane C, Montavon C, Faye MA, Gueye PM, Sow PS, Ndoye I, Gaye-Diallo A, Delaporte E, Peeters M, Mboup S. 2000. Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence. AIDS Res Hum Retroviruses 16:603-609.
42. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, et al. 2000. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 38:3919-3925.
43. Vergne L, Paraskevis D, Vandamme AM, Delaporte E, Peeters M. 2003. High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid. AIDS 17:1105-1107.